Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1035 | 2802 | 27.2 | 54% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1986 | 5072 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CAS 89396 94 1 | Author keyword | 18 | 89% | 0% | 8 |
2 | TA 6366 | Author keyword | 18 | 89% | 0% | 8 |
3 | MOEXIPRIL | Author keyword | 14 | 51% | 1% | 19 |
4 | IMIDAPRIL | Author keyword | 11 | 35% | 1% | 26 |
5 | FOSINOPRILAT | Author keyword | 6 | 58% | 0% | 7 |
6 | FOSINOPRIL | Author keyword | 6 | 20% | 1% | 27 |
7 | BENAZEPRIL | Author keyword | 6 | 18% | 1% | 28 |
8 | QUINAPRIL | Author keyword | 5 | 16% | 1% | 26 |
9 | CILAZAPRIL | Author keyword | 4 | 16% | 1% | 25 |
10 | SAFETY YODOGAWA KU | Address | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CAS 89396 94 1 | 18 | 89% | 0% | 8 | Search CAS+89396+94+1 | Search CAS+89396+94+1 |
2 | TA 6366 | 18 | 89% | 0% | 8 | Search TA+6366 | Search TA+6366 |
3 | MOEXIPRIL | 14 | 51% | 1% | 19 | Search MOEXIPRIL | Search MOEXIPRIL |
4 | IMIDAPRIL | 11 | 35% | 1% | 26 | Search IMIDAPRIL | Search IMIDAPRIL |
5 | FOSINOPRILAT | 6 | 58% | 0% | 7 | Search FOSINOPRILAT | Search FOSINOPRILAT |
6 | FOSINOPRIL | 6 | 20% | 1% | 27 | Search FOSINOPRIL | Search FOSINOPRIL |
7 | BENAZEPRIL | 6 | 18% | 1% | 28 | Search BENAZEPRIL | Search BENAZEPRIL |
8 | QUINAPRIL | 5 | 16% | 1% | 26 | Search QUINAPRIL | Search QUINAPRIL |
9 | CILAZAPRIL | 4 | 16% | 1% | 25 | Search CILAZAPRIL | Search CILAZAPRIL |
10 | TEMOCAPRIL | 4 | 30% | 0% | 10 | Search TEMOCAPRIL | Search TEMOCAPRIL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HOE 498 | 15 | 77% | 0% | 10 |
2 | MK 421 | 9 | 48% | 0% | 14 |
3 | MK521 | 6 | 80% | 0% | 4 |
4 | CI 906 | 6 | 71% | 0% | 5 |
5 | LISINOPRIL HYDROCHLOROTHIAZIDE COMBINATION | 6 | 100% | 0% | 4 |
6 | NORMOTENSIVE MAN | 5 | 55% | 0% | 6 |
7 | NEWER ACE INHIBITORS | 4 | 67% | 0% | 4 |
8 | LYSINE ANALOG MK 521 | 4 | 56% | 0% | 5 |
9 | MODERATE ESSENTIAL HYPERTENSION | 4 | 14% | 1% | 26 |
10 | ENALAPRIL MALEATE | 4 | 22% | 1% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CONVERTING-ENZYME INHIBITORS IN THE TREATMENT OF HYPERTENSION | 1988 | 369 | 70 | 71% |
ENALAPRIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE-HEART-FAILURE | 1986 | 277 | 155 | 72% |
QUINAPRIL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC EFFICACY IN CARDIOVASCULAR DISORDERS | 1991 | 54 | 49 | 86% |
CLINICAL PHARMACOKINETICS OF ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS IN RENAL-FAILURE | 1993 | 48 | 96 | 77% |
CLINICAL PHARMACOKINETICS OF THE NEWER ACE INHIBITORS - A REVIEW | 1990 | 76 | 90 | 88% |
CLINICAL PHARMACOKINETICS OF RAMIPRIL | 1994 | 25 | 26 | 100% |
PERINDOPRIL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CARDIOVASCULAR DISORDERS | 1991 | 60 | 77 | 70% |
Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension | 2008 | 21 | 137 | 44% |
CHOOSING THE RIGHT ACE-INHIBITOR - A GUIDE TO SELECTION | 1995 | 57 | 127 | 51% |
NEWER ACE INHIBITORS - A LOOK AT THE FUTURE | 1990 | 74 | 111 | 76% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SAFETY YODOGAWA KU | 4 | 75% | 0.1% | 3 |
2 | CLINCAL PHARMACOL | 1 | 50% | 0.0% | 1 |
3 | PAD DR DY PATIL MED | 1 | 50% | 0.0% | 1 |
4 | SANTE ANIM SA | 1 | 50% | 0.0% | 1 |
5 | WERK ROSENTAL | 1 | 25% | 0.1% | 2 |
6 | ANGERS TECHNOPOLE | 0 | 33% | 0.0% | 1 |
7 | HOSP THER Y 2 | 0 | 33% | 0.0% | 1 |
8 | MED EDUC FAMILY MED | 0 | 33% | 0.0% | 1 |
9 | PHARMACEUT BIOCHEM ENGN | 0 | 33% | 0.0% | 1 |
10 | SACRED CONVENT ANNUNCIAT | 0 | 33% | 0.0% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000222298 | TRANDOLAPRIL//MULTI PHOTON CONTAMINATION//VERAPAMIL SR TRANDOLAPRIL COMBINATION THERAPY |
2 | 0.0000167899 | ADR MONITORING//BOVINE BRONCHI//ACE I INHIBITOR |
3 | 0.0000149143 | UNITE PHYSIOL INTEGREE//ANGIOTENSIN II AT1 RECEPTOR ANTAGONIST//PATHOL VASC |
4 | 0.0000137311 | FLOSEQUINAN//BTS 53 554//FIRST DOSE HYPOTENSION |
5 | 0.0000101322 | MINICHAL//ANTIHYPERTENSIVE DRUG CLASSES//ANTIHYPERTENSIVE REGIMENS |
6 | 0.0000100643 | BLOOD FLOW ACCELERATION//EQUIPMENT AUTOMATIC BLOOD PRESSURE//STRAIN GAUGE VENOUS PLETHYSMOGRAPHY |
7 | 0.0000094213 | NONMODULATION//HYPERTENSION NONMODULATING//EXTREME NORTH |
8 | 0.0000087463 | CD143//ANGIOTENSIN I CONVERTING ENZYME//TESTICULAR ACE |
9 | 0.0000082875 | ADRENAL RENIN//ANGIOTENSINOGEN//TISSUE RENIN |
10 | 0.0000082459 | REDUCTIVE RING CLOSURE//THERMAL CYCLISATION//PHENOXYBENZAMINE HYDROCHLORIDE |